
Global & Mexico Cancer Therapeutics Market to 2031
Description
The cancer therapeutics market in Mexico is witnessing robust growth, driven by demographic shifts, economic development, and enhancements in healthcare infrastructure. According to the International Agency for Research on Cancer (IARC), approximately 210,000 new cancer cases were recorded in Mexico in 2022. Among these, breast cancer was the most prevalent, accounting for 15% of all diagnoses, followed by prostate cancer. The rising incidence of cancer is fueling demand for advanced treatment options, which in turn is propelling market expansion through innovation in drug development, personalized therapies, and increased investments in research and medical infrastructure.
The Mexican government has undertaken significant initiatives to improve healthcare accessibility, including the expansion of cancer care centers and the integration of advanced diagnostic tools. A key development was the establishment of the National Cancer Institute (INCan) as a regional center for cancer research and treatment, strengthening both clinical and scientific capacities. In July 2024, Zydus Lifesciences Ltd obtained marketing authorization from Mexico’s regulatory body for its Trastuzumab biosimilar, Mamitra, which is used to treat various forms of cancer. This approval marked an important step in the company’s strategy to broaden its presence in new markets and improve patient access to cost-effective, life-saving oncology therapies.
The Mexican government has undertaken significant initiatives to improve healthcare accessibility, including the expansion of cancer care centers and the integration of advanced diagnostic tools. A key development was the establishment of the National Cancer Institute (INCan) as a regional center for cancer research and treatment, strengthening both clinical and scientific capacities. In July 2024, Zydus Lifesciences Ltd obtained marketing authorization from Mexico’s regulatory body for its Trastuzumab biosimilar, Mamitra, which is used to treat various forms of cancer. This approval marked an important step in the company’s strategy to broaden its presence in new markets and improve patient access to cost-effective, life-saving oncology therapies.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Mexico Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Mexico Cancer Therapeutics Market – Analysis
- 6.1 Mexico Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Mexico Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Mexico Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Mexico Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Mexico Cancer Therapeutics Market Analysis – by Indications
- 8.1 Mexico Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Mexico Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Mexico Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Mexico Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Mexico Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Mexico Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Mexico Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Mexico Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Mexico Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Mexico Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Mexico Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Mexico Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Mexico Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.